Publish in this journal
Journal Information
Vol. 72. Issue 1.
Pages 86-88 (January 2019)
Share
Share
Download PDF
More article options
Vol. 72. Issue 1.
Pages 86-88 (January 2019)
Scientific letter
Full text access
Are Dentists in Our Environment Correctly Following the Recommended Guidelines for Prophylaxis of Infective Endocarditis?
¿Los odontólogos de nuestro medio siguen correctamente las pautas de profilaxis de endocarditis infecciosa recomendadas?
Visits
...
Paula Anguitaa,b, Manuel Anguitab,c,
Corresponding author
manuelanguita@secardiologia.es

Corresponding author:
, Juan C. Castilloc, Paula Gámezb, Victoria Bonillaa, Manuela Herreraa
a Facultad de Odontología, Universidad de Sevilla, Sevilla, Spain
b Instituto Cardiodental, Córdoba, Spain
c Servicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, Spain
Related content
Rev Esp Cardiol. 2019;72:9510.1016/j.rec.2018.07.013
Iria Silva Conde, Francisco Torres-Saura, Alberto Alperi García, Jesús María de la Hera Galarza
Article information
Full Text
Bibliography
Download PDF
Statistics
Tables (2)
Table 1. Prescription of Infective Endocarditis Prophylaxis by Dentists in At-risk Patients According to Indication, Lack of Indication, Dental Procedure and Manipulations, and Type of Cardiac Disease
Table 2. Prophylactic Antibiotic Regimens Used in Patients With and Without Beta-lactam Allergy
Show moreShow less
Full Text
To the Editor,

Infective endocarditis (IE) is a serious infection, with a very high mortality rate; prevention is essential. Before the publication of the North American clinical practice guidelines (CPG) in 20071 and the European guidelines in 2009,2 IE prophylaxis was recommended for patients with high or moderate risk heart disease. In those CPGs, the indications were limited to patients with high risk of IE (previous IE, valve replacements, cyanotic congenital heart disease, or congenital heart disease repairs with prosthetic material) and only in certain dental procedures or manipulations.1,2 The 2008 British NICE guidelines recommended no IE prophylaxis in any situation.3 In the most recent European CPG from 2015, recommendations were unchanged from 2009.4 These differences could lead to uncertainty about the approach to patients with possible risk of IE, as was already suggested by a previous study carried out in Spain.5 Out aim was to describe the current practice of dentists in view of these recommendations and analyze whether the approaches were uniform in 2 Spanish provinces.

One-hundred dentists from Córdoba and 100 from Seville were invited to complete a questionnaire on IE prophylaxis, via the Official College of Dentists of Córdoba and the Faculty of Dentistry of the University of Seville. The questionnaire was completed in full by 142 dentists; 62 in Seville and 80 in Córdoba (71% of all those invited; 62% in Seville and 80% in Córdoba). The chi-square test was used for comparisons between groups. P < .05 was considered statistically significant. There were no differences between the 2 provinces regarding the dentists’ age (44 ± 9 years in Seville vs 45 ± 10 years in Córdoba), years of practice (16 ± 5 vs 17 ± 5 in Córdoba) or sex (61.3% female in Seville and 51.2% in Córdoba, difference not statistically significant). Almost all (95.2%) of the respondents in Seville and 98.8% of those in Córdoba used prophylaxis in their everyday practice. Table 1A shows the dental procedures for which IE prophylaxis is indicated for at-risk patients. In most situations with a clear indication (surgery, implants, extractions, endodontics) or without indication (X-rays, anesthesia, removal of sutures, taking impressions for a prosthesis, fitting a removable prosthesis and orthodontic brackets), there was high compliance with the recommendations, except for endodontics and dental cleanings, in which antibiotic use was lower than recommended, and local anesthetic, in which use was higher than recommended (Table 1A).

Table 1.

Prescription of Infective Endocarditis Prophylaxis by Dentists in At-risk Patients According to Indication, Lack of Indication, Dental Procedure and Manipulations, and Type of Cardiac Disease

ASD, atrial septal defect; CPG, European or North American clinical practice guidelines; ICD, implantable cardioverter-defibrillator; VSD, ventricular septal defect.

Table 1B shows the heart conditions for which IE prophylaxis should and should not be used in dental interventions that carry risk. Of note is that in the 3 indications currently established by the North American and European CPGs (valve replacement, previous IE, cyanotic congenital heart disease or congenital heart disease repaired with prosthetic material), a very high proportion of dentists from both provinces used prophylaxis (Table 1B). In the case of prior indications that are no longer recommended, such as significant mitral or aortic valve disease, prophylaxis continues to be used by a very high proportion, as can be seen in Table 1B. However, even in situations without risk or with very low risk of IE (aortocoronary bypass, stents, isolated atrial fibrillation, mild mitral prolapse, closed interatrial or interventricular defects or ductus with no remaining defects) for which IE prophylaxis has never been recommended, it was prescribed by 50% to 70% of the dentists (Table 1B), with no differences between the 2 provinces studied.

Table 2 shows the antibiotic regimens used for IE prophylaxis. A total of 35% of the dentists in Seville and 36.7% of those in Córdoba used different antibiotics to those recommended (amoxycillin 2g as a single dose 1h before procedure). When asked about which micro-organisms they hoped to eradicate with IE prophylaxis, only 9.7% of the Seville dentists and 18.0% of the Córdoba dentists responded Streptococcus viridans only, while 92.3% and 88%, respectively, thought that they were eradicating other micro-organisms, such as enterococcus, staphylococcus, and Gram-negative bacilli.

Table 2.

Prophylactic Antibiotic Regimens Used in Patients With and Without Beta-lactam Allergy

The main conclusion of our study is that there is a notable knowledge gap and noncompliance with the current recommendations on IE prophylaxis among dentists in our setting, with overuse in patients in whom it is not currently recommended and, above all, in patients without risk of IE after dental procedures (those with coronary stents, aortocoronary bypass, mild mitral prolapse or even atrial fibrillation without structural disease). This could be an example of what has been described as the “no lose” philosopy.6 With the limitations of this study, which are those inherent to a voluntarily-completed questionnaire, it appears that there is a notable knowledge gap among dentists in our setting about important aspects of the recommended IE prophylaxis regimens. This translates to an excessive use of antibiotic prophylaxis in patients not at risk of IE. This knowledge gap was similar and uniform in the 2 provinces studied. It therefore seems necessary to develop educational strategies on this disease for all the professional groups involved. To achieve this, the coordination and collaboration of all the related scientific societies will be essential.

REFERENCES
[1]
W. Wilson, K. Taubert, M. Gewitz, et al.
Prevention of infective endocarditis. Guidelines from the American Heart Association.
Circulation., 116 (2007), pp. 1736-1754
[2]
G. Habib, B. Hoen, P. Tornos, et al.
The Task Force for the prevention, diagnosis and treatment of infective endocarditis of the ESC.
Eur Heart J., 30 (2009), pp. 2369-2413
[3]
R. Richey, D. Wray, T. Stokes.
Prophylaxis against infective endocarditis: summary of NICE guidance.
[4]
G. Habib, P. Lancellotti, M.J. Antunes, et al.
Task Force for the Management of infective endocarditis of the ESC. 2015 Guidelines for the management of infective endocarditis.
Eur Heart J., 36 (2015), pp. 3075-3128
[5]
M. González de Molina, J.C. Fernández-Guerrero, J. Azpitarte.
Infectious Endocarditis: Degree of Discordance Between Clinical Guidelines Recommendations and Clinical Practice.
Rev Esp Cardiol., 55 (2002),
793-780
[6]
D. Shaw, D.I. Conway.
Pascal's Wager, infective endocarditis and the “no-lose” philosophy in medicine.
Heart., 96 (2010), pp. 15-18
Idiomas
Revista Española de Cardiología (English Edition)

Subscribe to our newsletter

Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?